期刊文献+

加味补阳还五汤对心肌梗死后慢性心力衰竭患者Lp-PLA2、hs-CRP及NT-proBNP的影响 被引量:24

The effect of Buyang Huanwu Decoction on Lp-PLA2,hs-CRP and NTproBNP in patients with chronic heart failure after myocardial infarction
原文传递
导出
摘要 目的探讨加味补阳还五汤治疗心肌梗死后慢性心力衰竭患者的疗效。方法将78例心肌梗死后慢性心力衰竭患者随机分为对照组(n=38)和治疗组(n=40)。对照组给予常规抗心衰治疗,包括利尿剂、硝酸异山梨脂类药物、酌情使用洋地黄制剂、血管紧张素转化酶抑制剂(ACEI)或血管紧张素II受体阻滞剂(ARB)、β-受体阻滞剂等;治疗组在对照组基础上加用加味补阳还五汤治疗,4周为1个疗程。分别观察治疗组与对照组治疗前后NYHA心功能分级、中医证候积分的改善情况,测定2组6 min试验距离及脂蛋白磷脂酶(Lp-PLA2)、超敏C反应蛋白(hs-CRP)及B型氨基端利钠肽原(NT-pro BNP)水平等。结果治疗组NYHA分级评定临床疗效明显高于常规治疗组(P<0.05);治疗组中医证候疗效明显高于对照组(P<0.05);治疗组治疗后6 min试验距离明显高于对照组,差异有统计学意义(P<0.05);治疗组治疗后Lp-PLA2、hs-CRP、NT-pro BNP分别为(228.82±58.92)mg/L、(3.11±1.85)mg/L、(468.18±182.37)ng/L,对照组分别为(252.47±69.49)mg/L、(4.36±2.26)mg/L、(722.63±263.16)ng/L,显著高于治疗组(P<0.05)。结论加味补阳还五汤可明显改善心肌梗死后心力衰竭患者的临床症状,改善心功能,其作用机制可能与减轻机体炎症反应,防止和延缓心肌重构相关。 Objective To investigate the effect of Buyang Huanwu Decoction on chronic heart failure after myocardial infarction. Methods 78 patients with chronic heart failure after myocardial infarction were randomly divided into control group( n = 38) and treatment group( n = 40). The control group was treated with conventional anti-heart failure therapy,including diuretics,isosorbide mononitrate,ACEI,ARB,beta blockers,and so on. The treatment group was treated with the addition of Buyang Huanwu Decoction on the basis of the control group,and the treatment lasted 4 weeks. The improvement of NYHA classification of cardiac function,TCM syndrome score in both groups before and after treatment were observed,respectively. The distance of 6 min test,the levels of Lp-PLA2,hs-CRP and NT-pro BNP were recorded. Results The effect of the treatment group was significantly higher than that of the control group( P〈0. 05). The curative effect of TCM syndrome in treatment group was significantly higher than that of control group( P〈0. 05). After treatment,the distance of 6 min test was significantly higher than control group,and the difference was statistically significant( P〈0. 05). The Lp-PLA2,hs-CRP,NT-proBNP in the treatment group were( 228. 82 ± 58. 92) mg/L,( 3. 11 ± 1. 85) mg/L,( 468. 18 ± 182. 37) ng/L; in the control group were( 252. 47 ± 69. 49) mg/L,( 4. 36 ± 2. 26) mg/L,( 722. 63 ± 263. 16) ng/L,which were significantly higher than treatment group( P〈0. 05). Conclusion Buyang Huanwu Decoction could significantly improve the clinical symptoms and cardiac function of patients with heart failure after myocardial infarction. The mechanism may be related to the reduction of the inflammatory response in patients with myocardial infarction and the prevention of myocardial remodeling.
出处 《现代中医临床》 2017年第3期16-19,共4页 Modern Chinese Clinical Medicine
基金 广东省中医药管理局科研课题(No.20151106) 韶关市卫生计生科研计划项目(No.Y15060)
关键词 慢性心力衰竭 心肌梗死 补阳还五汤 脂蛋白磷脂酶 超敏C反应蛋白 B型氨基端利钠肽原 chronic heart failure miocardial infarction Buyang Huanwu Decoction Lp-PLA2 hs-CRP NT-proBNP
  • 相关文献

参考文献7

二级参考文献115

  • 1史小琴,张明艳,冯浩楼.心肌肌钙蛋白T在心血管病诊断中的作用[J].河北职工医学院学报,2000,17(3):64-65. 被引量:2
  • 2潘柏申,蔡乃绳,李清,范维琥,李勇,郭玮,周琰,陶青.表面健康人群氨基末端B型利钠肽参考范围调查[J].中华检验医学杂志,2006,29(1):23-26. 被引量:66
  • 3李世强,傅向华,刘君,谷新顺,张晶,樊欣娜,姜云发,苗青.静脉注射重组人脑利钠肽对急性心肌梗死伴心力衰竭患者的急性血流动力学效应的研究[J].中华心血管病杂志,2006,34(1):23-27. 被引量:102
  • 4王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量:91
  • 5HIGUCHI Y,MCTIERNAN C F,FRYE C B,et al.Tumor necrosis factor receptors 1 and 2 differentially regulate survival,cardiac dysfunction,and remodeling in transgenic mice with tumor necrosis factor-alpha induced cardiomyopathy [J].Circulation,2004,109 (15):1892-1897. 被引量:1
  • 6TSUTAMOTO T,WADA A,OHNISHI M T,et al.Transcardiac increase in tumor necrosis factor-alpha and left ventricular end-diastolic volume in patients with dilated cardiomyopathy [ J ].Eur J Heart Fail,2004,6(2):173-180. 被引量:1
  • 7GAO C Q,SAWICKI G,SUAREZ-PINZON W L,et al.Matrix metalloproteinase-2 mediates cytokine-induced myocardial contractile dysfunction[J].Cardiovasc Res,2003,57 (2):426-433. 被引量:1
  • 8SETSUTA K,SEINO Y,OGAWA T,et al.Ongoing myocardial damage in chronic heart failure is related to activated tumor necrosis factor and Fas/ Fas ligand system [J].Jpn Circ J,2004,68 (8):747-750. 被引量:1
  • 9DESWAL A,BOZKURT B,SETA Y,et al.Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel,etanercept) in patients with advanced heart failure [ J].Circulation,1999,99 (25):3224-3226. 被引量:1
  • 10MANN D L,MCMURRAY J J,PACKER M,et al.Targeted anticytokine therapy in patients with chronic heart failure:results of the Randomized Etanercept Worldwide Evaluation (RENEWAL) [ J ].Circulation,2004,109 (13):1594-1602. 被引量:1

共引文献3807

同被引文献269

引证文献24

二级引证文献106

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部